These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10690937)
1. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. De Marinis L; Mancini A; Valle D; Bianchi A; Gentilella R; Milardi D; Mascadri C; Giustina A Metabolism; 2000 Feb; 49(2):155-9. PubMed ID: 10690937 [TBL] [Abstract][Full Text] [Related]
2. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity. Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741 [TBL] [Abstract][Full Text] [Related]
3. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504 [TBL] [Abstract][Full Text] [Related]
4. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418 [TBL] [Abstract][Full Text] [Related]
6. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. Giusti M; Foppiani L; Ponzani P; Cuttica CM; Falivene MR; Valenti S J Endocrinol Invest; 1997 May; 20(5):257-63. PubMed ID: 9258804 [TBL] [Abstract][Full Text] [Related]
7. Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa. De Marinis L; Mancini A; D'Amico C; Zuppi P; Tofani A; Della Casa S; Saporosi A; Sambo P; Fiumara C; Calabró F Psychoneuroendocrinology; 1991; 16(6):499-504. PubMed ID: 1811245 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity. Pincelli AI; Rigamonti AE; Scacchi M; Cella SG; Cappa M; Cavagnini F; Müller EE Eur J Endocrinol; 2003 Feb; 148(2):237-43. PubMed ID: 12590644 [TBL] [Abstract][Full Text] [Related]
9. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576 [TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers. Casanueva FF; Borras CG; Burguera B; Lima L; Muruais C; Tresguerres JA; Devesa J Clin Endocrinol (Oxf); 1987 Nov; 27(5):517-23. PubMed ID: 2897260 [TBL] [Abstract][Full Text] [Related]
12. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment. Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312 [TBL] [Abstract][Full Text] [Related]
13. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa. Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048 [TBL] [Abstract][Full Text] [Related]
14. Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women. Arvat E; Maccagno B; Ramunni J; Broglio F; Lanfranco F; Giordano R; Benso A; Deghenghi R; Ghigo E J Endocrinol Invest; 1998 Nov; 21(10):673-9. PubMed ID: 9854683 [TBL] [Abstract][Full Text] [Related]
15. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease. Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769 [TBL] [Abstract][Full Text] [Related]
16. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511 [TBL] [Abstract][Full Text] [Related]
17. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa. Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699 [TBL] [Abstract][Full Text] [Related]
18. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916 [TBL] [Abstract][Full Text] [Related]
19. The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans. Todd JF; Edwards CM; Ghatei MA; Bloom SR Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1060-6. PubMed ID: 10827009 [TBL] [Abstract][Full Text] [Related]
20. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation. Bondanelli M; Ambrosio MR; Margutti A; Boldrini P; Basaglia N; Franceschetti P; Zatelli MC; Degli Uberti EC Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]